Quantinno Capital Management LP increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 332.2% during the first quarter, Holdings Channel reports. The institutional investor owned 422,577 shares of the medical device company’s stock after purchasing an additional 324,800 shares during the quarter. Quantinno Capital Management LP’s holdings in Cooper Companies were worth $30,214,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp raised its holdings in Cooper Companies by 2.4% in the 4th quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after acquiring an additional 207,195 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after acquiring an additional 4,756,178 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in shares of Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares in the last quarter. Sustainable Growth Advisers LP grew its holdings in shares of Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after purchasing an additional 747,476 shares in the last quarter. Finally, Franklin Resources Inc. increased its position in shares of Cooper Companies by 108.2% during the fourth quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after purchasing an additional 2,089,763 shares during the period. 24.39% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
COO has been the subject of a number of recent research reports. Needham & Company LLC cut their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Stifel Nicolaus decreased their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Finally, UBS Group began coverage on shares of Cooper Companies in a report on Tuesday. They set a “neutral” rating and a $75.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, Cooper Companies presently has a consensus rating of “Hold” and a consensus target price of $81.36.
Cooper Companies Trading Down 0.5%
COO stock opened at $72.32 on Friday. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The business’s 50 day moving average is $68.36 and its 200-day moving average is $71.79. The firm has a market cap of $14.10 billion, a P/E ratio of 61.29, a P/E/G ratio of 1.90 and a beta of 0.84.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.
Cooper Companies Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Read More
- Five stocks we like better than Cooper Companies
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
